You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

urico-lowering therapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Gout, Gout Initiating Urico-lowering Therapy Trial in Shanghai (Genakumab for injection, Etoricorxib)

Not yet recruiting
  • Acute Gout
  • Gout Initiating Urico-lowering Therapy
  • Shanghai, Shanghai, China
    Fudan University Affiliated Huashan Hospital
Jun 30, 2023

Coronary Artery Disease Progression Trial in Amsterdam

Recruiting
  • Coronary Artery Disease Progression
    • Amsterdam, Noord-Holland, Netherlands
      Amsterdam UMC, location AMC
    Mar 23, 2023

    Adverse Effect of Cardiovascular Medications (Diagnosis) Trial in Zibo (Evolocumab combined with statins, Statin)

    Recruiting
    • Adverse Effect of Cardiovascular Medications (Diagnosis)
    • Evolocumab combined with statins
    • Statin
    • Zibo, Shandong, China
      Zibo Central Hospital
    Mar 24, 2023

    Prostate Cancer, Recurrent Prostate Cancer, PET Positive Trial run by the National Cancer Institute (NCI) (Enzalutamide, M9241)

    Not yet recruiting
    • Prostate Cancer
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Oct 27, 2023

    Dyslipidemias, Atherosclerotic Cardiovascular Disease Trial in Amman

    Not yet recruiting
    • Dyslipidemias
    • Atherosclerotic Cardiovascular Disease
      • Amman, Jordan
      • +1 more
      Nov 23, 2022

      Hypercholesterolemia Trial (Inclisiran, Ezetimibe, Matching Placebo for Inclisiran)

      Not yet recruiting
      • Hypercholesterolemia
      • (no location specified)
      Feb 28, 2023

      Inclisiran Plus Standard of Care Lipid-lowering Therapy Compared

      Recruiting
      • Primary Hypercholesterolemia
      • Mixed Dyslipidemia
      • Inclisiran
      • Geneve 14, Switzerland
        Novartis Investigative Site
      Nov 14, 2022

      Dyslipidemias Trial in Samara (Combined Lipid-lowering Therapy)

      Recruiting
      • Dyslipidemias
      • Combined Lipid-lowering Therapy
      • Samara, Russian Federation
        Samara Regional Cardiology Dispansery
      Nov 17, 2022

      Extracellular Vesicles for HD

      Not yet recruiting
      • Huntington Disease
        • (no location specified)
        Oct 17, 2023

        Gout, Inflammatory Rheumatism, Hyperuricemia Trial in Paris (Cleanweb electronic messaging ePro, Usual follow-up)

        Recruiting
        • Gout
        • +3 more
        • Cleanweb electronic messaging ePro
        • Usual follow-up
        • Paris, Ile-De-France, France
        • +1 more
        Aug 29, 2022

        Treatment Side Effects Trial in Sao Paulo (Lipid-lowering agents (Artovastatin))

        Terminated
        • Treatment Side Effects
        • Lipid-lowering agents (Artovastatin)
        • Sao Paulo, Brazil
          Samuel Katsuyuki Shinjo
        May 31, 2022

        Gout, CKD Stage 1-4, SUA Level (>8 mg/dL; 480 µmol/L) Trial in Kiev (Febuxostat 80 MG Oral Tablet or Allopurinol 300 MG Oral

        Enrolling by invitation
        • Gout
        • +2 more
        • Febuxostat 80 MG Oral Tablet or Allopurinol 300 MG Oral Tablet
        • Kiev, Ukraine
          Medical Practice Prof D.Ivanov
        Aug 22, 2022

        LDL-cholesterol Trial in Jena (statins, ezetimibe, bempedoic acid, evolocumab, alirocumab, inclisiran)

        Recruiting
        • LDL-cholesterol
        • statins, ezetimibe, bempedoic acid, evolocumab, alirocumab, inclisiran
        • Jena, Thuringia, Germany
          University Hospital Jena
        Oct 17, 2022

        Infection, Transplant;Failure,Kidney Trial in San Francisco (Mycophenolate Mofetil)

        Withdrawn
        • Infection
        • Transplant;Failure,Kidney
        • Mycophenolate Mofetil
        • San Francisco, California
          University of California, San Francisco
        May 2, 2022

        Russian Coronary Heart Disease <<Treat to Goal>> (Study P05464)

        Completed
        Has Results
        • Coronary Heart Disease
        • Hypercholesterolemia
        • (no location specified)
        Feb 7, 2022

        Aging Trial in Boulder (Heat therapy, Thermoneutral water immersion)

        Recruiting
        • Aging
        • Heat therapy
        • Thermoneutral water immersion
        • Boulder, Colorado
          University of Colorado Boulder
        Apr 22, 2022

        Compliance With LDL-Lowering Therapy (Study P05467)(COMPLETED)

        Completed
        • Coronary Heart Disease
        • +2 more
        • (no location specified)
        Feb 7, 2022

        Myocardial Infarction, Acute, Myocardial Strain, Arterial Stiffness Trial in Penza (Atorvastatin 80mg)

        Recruiting
        • Myocardial Infarction, Acute
        • +3 more
        • Atorvastatin 80mg
        • Penza, Russian Federation
          Valentin Oleynikov
        May 10, 2022

        In-stent Restenosis Trial in Beijing (Colchicine, Prednisone, Aspirin)

        Not yet recruiting
        • In-stent Restenosis
        • Beijing, Beijing, China
          Fuwai Hospital
        Oct 15, 2023

        Tophaceous Gout Trial in Paris (Dual-Energy Computed Tomography examination)

        Recruiting
        • Tophaceous Gout
        • Dual-Energy Computed Tomography examination
        • Paris, Ile De France, France
        • +1 more
        Sep 8, 2022

        Ezetimibe Achieved in Co-administration Therapy With Statins

        Completed
        Has Results
        • Hypercholesterolemia
        • (no location specified)
        Feb 7, 2022

        The Belgian REAL (BE.REAL) Registry

        Not yet recruiting
        • Atherosclerotic Cardiovascular Disease
        • Inclisiran
        • (no location specified)
        Feb 3, 2023

        STEMI, Covid19, NSTEMI Trial in Penza (Atorvastatin 80mg, Atorvastatin-Ezetimibe)

        Recruiting
        • STEMI
        • +2 more
        • Penza, Russian Federation
          Valentin Oleynikov
        May 10, 2022

        Cardiovascular Diseases, Hyper-LDL-cholesterolemia Trial in Cincinnati (lerodalcibep)

        Active, not recruiting
        • Cardiovascular Diseases
        • Hyper-LDL-cholesterolemia
        • Cincinnati, Ohio
        • +2 more
        Nov 3, 2022

        Clinical Trial, Acute Coronary Syndrome Trial in Seoul (Evolocumab, NIRS IVUS)

        Recruiting
        • Clinical Trial
        • Acute Coronary Syndrome
        • Seoul, Korea, Republic of
          Korea University Anam Hospital
        Mar 28, 2022